Basit öğe kaydını göster

dc.contributor.authorUzun, O
dc.contributor.authorAkpolat, T
dc.contributor.authorErkan, L
dc.date.accessioned2020-06-21T15:36:52Z
dc.date.available2020-06-21T15:36:52Z
dc.date.issued2005
dc.identifier.issn0012-3692
dc.identifier.issn1931-3543
dc.identifier.urihttps://doi.org/10.1378/chest.127.6.2243
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21078
dc.descriptionWOS: 000229767300056en_US
dc.descriptionPubMed: 15947344en_US
dc.description.abstractStudy objectives: The aims of this study were to investigate the frequency of pulmonary problems in Behcet disease (BD), and to discuss lesser-known features of pulmonary BD such as clinical characteristics, analysis of prognosis, and evaluation of treatment options with respect to the previously published cases. Design: We conducted a comprehensive review of the literature to analyze cumulated data about pulmonary involvement in BD. Setting: We found 159 articles regarding pulmonary disease associated with BD in May 2003. Patients: The evaluation of these articles demonstrated 598 pulmonary problems in 585 cases. Results: Pulmonary artery aneurysms (PAAs) are the most common pulmonary lesion in BD, and these are almost always associated with hemoptysis. Seventy-eight percent of patients with aneurysms have concomitant extrapulmonary venous thrombi or thrombophlebitis. Other pulmonary problems are reported in BD, and these are principally related to vascular lesions and radiologic abnormalities. Conclusions: Pulmonary vascular problems, either PAA or involvement of small-sized vessels, are the main pulmonary disorders in BD. Immunopathologic findings indicate that the underlying pathogenesis is pulmonary vasculitis, which may result in thrombosis, infarction, hemorrhage, and PAA formation. Patients with small nonspecific radiologic abnormalities should be followed up closely since early diagnosis of vascular lesions may be life-saving. Immunosuppression is the main therapy for the treatment of a vasculitis. It is important that pulmonary angiitis is not mistaken for pulmonary thromboembolic disease since fatalities have occurred in BD shortly after initiation of anticoagulation/thrombolytic treatment.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1378/chest.127.6.2243en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectanticoagulationen_US
dc.subjectBehcet diseaseen_US
dc.subjectimmunosuppressionen_US
dc.subjectpulmonary artery aneurysmen_US
dc.subjectpulmonary thromboembolic diseaseen_US
dc.subjectvasculitisen_US
dc.titlePulmonary vasculitis in Behcet disease - A cumulative analysisen_US
dc.typereviewen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume127en_US
dc.identifier.issue6en_US
dc.identifier.startpage2243en_US
dc.identifier.endpage2253en_US
dc.relation.journalChesten_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster